A new FAQ sheet from the US Department of Health and Human Services (HHS) defends its recent decision to remove Food and Drug Administration oversight of laboratory developed tests, saying the agency “rarely enforced” premarket review of LDTs in the first place.
“FDA will no longer require premarket review of tests developed by a laboratory for use solely within that lab (laboratory developed tests, or LDTs), due to a determination by the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?